Skip to content
CO
Company

Updated:

CytRx Oncology Corp

CytRx Oncology Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001337223, and its reported industry is...

Overview

CytRx Oncology Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001337223, and its reported industry is Biological Products, (No Diagnostic Substances). The retained history contains 12 filings, including 10-Q filed on 2008-08-14. Each filing retains its accession, filing date and original SEC document link. This historical evidence does not establish current registration, listing, ownership or financial condition.

Company overview

Legal name
CytRx Oncology Corp
Former names in filing history
Innovive Pharmaceuticals, Inc. (2005-07-15 to 2008-08-14)
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
New York, NY, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001337223

Recent SEC filings

FormFiledPeriodFiling
10-QFORM 10-Q
8-KFORM 8-K
8-KFORM 8-K
10-QFORM 10-Q
10-K/AFORM 10-K/A
10-KFORM 10-K
8-KINNOVIVE PHARMACEUTICALS, INC.
10-QFORM 10-Q
8-KINNOVIVE PHARMACEUTICALS, INC.
8-KINNOVIVE PHARMACEUTICALS, INC.
8-KINNOVIVE PHARMACEUTICALS, INC.
10-QFORM 10-Q

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research CytRx Oncology Corp in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

CytRx Oncology Corp | New York Company | Altss